Osurnia 1 mg Gel is a Health Canada–registered veterinary drug (DIN 02438534) held by Dechra Ltd, containing Betamethasone Acetate. Health Canada lists its status as Marketed (status date 06 Oct 2021). Nexara Health has matched 816 registrations of Betamethasone Acetate across 34 other regulated markets.
Health Canada registration
| DIN | 02438534 |
|---|---|
| Brand name | Osurnia |
| Active ingredient | Betamethasone Acetate |
| Strength | 1 mg |
| Dosage form | Gel |
| Route | Otic |
| Company | Dechra Ltd |
| Status | Marketed — 06 Oct 2021 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Betamethasone Acetate registered in other markets
816 registrations of the same molecule in 34 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Betnovate | As | Cream 1 mg (as valerate) per g, 30 g | R1 | PBS | |
| Australia | Betnovate | As | Ointment 1 mg (as valerate) per g, 30 g | R1 | PBS | |
| Australia | Betnovate 1/2 | As | Cream 500 micrograms (as valerate) per g, 15 g | GE | PBS | |
| Australia | Betnovate 1/2 | As | Cream 500 micrograms (as valerate) per g, 15 g | GE | PBS | |
| Australia | Betnovate 1/5 | As | Cream 200 micrograms (as valerate) per g, 100 g | GE | PBS | |
| Australia | Celestone Chronodose | Oq | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | GE | PBS | |
| Australia | Celestone Chronodose | Oq | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | GE | PBS | |
| Australia | Cortival 1/2 | Ln | Cream 500 micrograms (as valerate) per g, 15 g | GE | PBS | |
| Austria | Betnesol Augen-, Ohren-, Nasentropf. | — | 5ml | green box | eEKO (Erstattungskodex) | |
| Austria | Betnesol Brausetabl. | — | 30St | green box | eEKO (Erstattungskodex) | |
| Austria | Betnesol Brausetabl. | — | 10St | green box | eEKO (Erstattungskodex) | |
| Austria | Betnovate crinale Lsg. | — | 30ml | green box | eEKO (Erstattungskodex) | |
| Austria | Betnovate Salbe | — | 30g | green box | eEKO (Erstattungskodex) | |
| Austria | Celestan Biphase Amp. 1 ml | — | 1St | green box | eEKO (Erstattungskodex) | |
| Austria | Celestan Biphase Amp. 1 ml | — | 5St | green box | eEKO (Erstattungskodex) | |
| Austria | Diproderm Creme | — | 15g | green box | eEKO (Erstattungskodex) | |
| Bahrain | Betaderm | Egyptian International Pharmaceutical Industries Co. (Eipico), Egypt. | 0.1 % | Cream | POM | NHRA |
| Bahrain | Betaderm | Egyptian International Pharmaceutical Industries Co. (Eipico), Egypt. | 0.1 % | Cream | POM | NHRA |
| Bahrain | Betamed | Medpharma Pharmaceutical & Chemical Industries LLC, Uae. | 0.1 % W/W | Cream | POM | NHRA |
| Bahrain | Betasone | Gulf Pharmaceutical Industries (Julphar), Uae. | 0.1 % W/W | Cream | POM | NHRA |
| Bahrain | Betasone | Gulf Pharmaceutical Industries (Julphar), Uae. | 0.1 % W/W | Ointment | POM | NHRA |
| Bahrain | Betnovate | Glaxo Wellcome Uk Limited, Uk. | 0.1 %W/W | Scalp Application | POM | NHRA |
| Bahrain | Betnovate | Glaxo Wellcome Uk Limited, Uk. | 0.1 % W/W | Cream | POM | NHRA |
| Bahrain | Bevason | Oman Pharmaceutical Products Co. LLC (Zynova), Oman. | 0.1 % | Cream | POM | NHRA |
| Bolivia | Betametasona (fosfato) | — | 4 mg | Inyectable | LINAME (formulary) | |
| Bulgaria | Betaderm A | Bausch Health Ireland Limited | 0,5 mg /g + 30 mg /g ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Betazon | Антибиотик-Разград | 1 mg/g cream | крем | По лекарско предписание | BDA |
| Bulgaria | Betazon | Антибиотик - Разград АД | 1 mg/g ointment | маз | По лекарско предписание | BDA |
| Bulgaria | BetazonTab | Антибиотик-Разград АД | 0,5 mg tablets | таблетка | По лекарско предписание | BDA |
| Bulgaria | Diprophos | N.V. Organon | 7 mg/ml suspension for injection | суспензия за инжектиране | По лекарско предписание | BDA |
| Bulgaria | Diprosalic | N.V. Organon | 0,5 mg/g+20mg/g cutaneous solution | дермален разтвор | По лекарско предписание | BDA |
| Bulgaria | Diprosalic | N.V. Organon | 0,5 mg/30 mg/g ointment | маз | По лекарско предписание | BDA |
| Bulgaria | Diprosone | N.V. Organon | 0,05% ointment | маз | По лекарско предписание | BDA |
| Croatia | Beloderm | Belupo d.d. | krema 1x30 g (0,5 mg/g) | R | HZZO | |
| Croatia | Beloderm | Belupo d.d. | mast 1x30 g (0,5 mg/g) | R | HZZO | |
| Croatia | Betazon | Jadran - Galenski Laboratorij d.d. | krema 1x25 g (0,5 mg/g) | R | HZZO | |
| Czech Republic | Beloderm | — | 0,5MG/G | Drm Sol | R | SUKL DLP |
| Czech Republic | Beloderm | — | 0,5MG/G | Ung | R | SUKL DLP |
| Czech Republic | Beloderm | — | 0,5MG/G | Crm | R | SUKL DLP |
| Czech Republic | Belosalic | — | 0,5MG/G+20MG/G | Drm Spr Sol | R | SUKL DLP |
| Czech Republic | Belosalic | — | 0,5MG/G+20MG/G | Drm Sol | R | SUKL DLP |
| Czech Republic | Belosalic | — | 0,5MG/G+30MG/G | Ung | R | SUKL DLP |
| Czech Republic | Diprosalic | — | 0,5MG/G+20MG/G | Drm Sol | R | SUKL DLP |
| Czech Republic | Diprosalic | — | 0,5MG/G+30MG/G | Ung | R | SUKL DLP |
| Denmark | Bekuval | 2care4 Generics ApS | 1 mg/ml | kutanopløsning | National | Laegemiddelstyrelsen |
| Denmark | Bemeson | 2care4 Generics ApS | 1 mg/g | creme | National | Laegemiddelstyrelsen |
| Denmark | Betamethason "Ebb Medical" | Ebb Medical AB | 1 mg/g | creme | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Betamethason "Nordic Prime" | Nordic Prime ApS | 1 mg/g | creme | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Betamethason "Orifarm" | Orifarm A/S | 1 mg/g | creme | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Betnovat | GlaxoSmithKline Pharma A/S | 1 mg/g | salve | National | Laegemiddelstyrelsen |
| Denmark | Betnovat | 2care4 ApS | 1 mg/g | salve | Par-Imp | Laegemiddelstyrelsen |
| Denmark | Betnovat | GlaxoSmithKline Pharma A/S | 1 mg/ml | kutanopløsning | National | Laegemiddelstyrelsen |
| Dominican Republic | Inflacor | Laboratorios Chalver De Colombia S.a., Colombia | Registered | MISPAS | ||
| Finland | Bemetson | Orion Corporation | 0.1 % | emulsiovoide | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bemetson | Orion Corporation | 0.1 % | voide | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Bemetson | Orion Corporation Orion Pharma | 1 mg/ml | linimentti | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Bemetson | Orion Corporation | 1 mg/ml | liuos päänahkaan | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Betapred | ALFASIGMA S.p.A. | 4 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Betnovat | GlaxoSmithKline Oy | 1 mg/g | voide | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Betnovat | GlaxoSmithKline Oy | 1 mg/g | emulsiovoide | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Betnovat | GlaxoSmithKline Oy | 1 mg/ml | liuos iholle | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Greece | Betnovate Cream 0,1% (W/W) Tubx30g | Glaxosmithkline Μονοπροσωπη Ανωνυμη Εμπορικη Και Βιομηχανικη Εταιρεια Φαρμακευτικων Προϊοντων Δ.τ. Glaxosmithkline Μονοπροσωπη Α.ε.β.ε. | reimbursed | MoH deltio timwn | ||
| Greece | Betnovate Cut.sol 0,1% mg/mL Flx50ml Scalp Applic | Glaxosmithkline Μονοπροσωπη Ανωνυμη Εμπορικη Και Βιομηχανικη Εταιρεια Φαρμακευτικων Προϊοντων Δ.τ. Glaxosmithkline Μονοπροσωπη Α.ε.β.ε. | reimbursed | MoH deltio timwn | ||
| Greece | CELESTONE CHRONODOSE INJ.SU.RET (3+3)MG/1 ML VIAL BTx1VIALx1ML | N.v. Organon Holland | reimbursed | MoH deltio timwn | ||
| Greece | Flogozyme Lot 0,1% W/V Flx50ml | Ταργκετ Φαρμα Μονοπροσωπη Εταιρεια Περιορισμενης Ευθυνης Δ.τ. Target Pharma Μονοπροσωπη Επε, Ελλαδα | reimbursed | MoH deltio timwn | ||
| Greece | Movithiol Cream 0,1% Tubx25g | Iasis Pharmaceuticals Hellas Βιομηχανια Και Εμπορια Φαρμακευτικων - Χημικων Και Καλλυντικων Προιοντων Α.β.ε.ε., Δ.τ. Iasis Pharma | reimbursed | MoH deltio timwn | ||
| Greece | Osmoran Lot 0.1% W/V(Bet.val) Flx60ml | Rafarm A.e.b.e. | reimbursed | MoH deltio timwn | ||
| Greece | PROPIOCHRONE INJ.SUSP (5+2)MG/1ML BTx1AMPx1ML | N.v. Organon Holland | reimbursed | MoH deltio timwn | ||
| Hong Kong | Axcel Betamethasone Cream 0.1% | Kotra Pharma (Hong Kong) Company | Registered | DH Drug Office | ||
| Hong Kong | Benosone Cream 0.1% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Benosone Ointment 0.1% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Beprogel Topical Soln 0.05% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Beprosone Cream 0.05% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Beprosone Oint 0.05% | Taisho Pharmaceutical (Hk) Ltd | Registered | DH Drug Office | ||
| Hong Kong | Beta Cream 0.1% | Jean-Marie Pharmacal Co Ltd | Registered | DH Drug Office | ||
| Hong Kong | Beta-Dexalone Tab 0.5mg | Wilcome Pharmaceutical Co Ltd | Registered | DH Drug Office | ||
| Hungary | Diprosalic Kenőcs | Organon Hungary Korlátolt Felelősségű Társaság | 1x30g tubusban | NEAK PUPHA | ||
| Hungary | Diprosalic Oldat | Organon Hungary Korlátolt Felelősségű Társaság | 1x30ml tartályban | NEAK PUPHA | ||
| Iceland | Betapred | Lyfjaver - óskráð lyf | 4 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Betapred | Icepharma - óskráð | 0,5 mg | lausnart | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Betapred | Icepharma - óskráð | 4 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Betnesol | Parlogis - óskráð lyf | 0,5 mg | lausnart | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Betnovat | GlaxoSmithKline Pharma A/S | 1 mg/g | húðlausn | 1 | Lyfjastofnun lyfjaverdskra |
| Iceland | Diprosalic | N.V. Organon | húðlausn | 1 | Lyfjastofnun lyfjaverdskra | |
| Iceland | Diprosone | Distica - óskráð lyf | 0,05 % | krem | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Diprospan | N.V. Organon | 7 mg/ml | stl | 1 | Lyfjastofnun lyfjaverdskra |
| Ireland | Betacap Scalp Application 0.1 % w/w cutaneous solution | Dermal Laboratories (Ireland) Limited | Cutaneous solution | Marketed | HPRA | |
| Ireland | Betnesol 0.1% w/v Eye, Ear and Nasal Drops, solution | RPH Pharmaceuticals AB | Ear/eye/nasal drops, solution | Marketed | HPRA | |
| Ireland | Betnovate Cream 0.1% w/w | GlaxoSmithKline (Ireland) Limited | Cream | Marketed | HPRA | |
| Ireland | Betnovate Ointment 0.1% w/w | GlaxoSmithKline (Ireland) Limited | Ointment | Marketed | HPRA | |
| Ireland | Betnovate Scalp Application 0.1% w/w Cutaneous Solution | GlaxoSmithKline (Ireland) Limited | Cutaneous solution | Marketed | HPRA | |
| Ireland | Bettamousse 1 mg/g (0.1%) cutaneous foam | RPH Pharmaceuticals AB | Cutaneous foam | Marketed | HPRA | |
| Luxembourg | BETNELAN-V POMM. 0,1 PC 1*1 tube 30 g | — | RR | CNS liste positive | ||
| Luxembourg | BETNELAN-V SOL.APP.CUT 0,1 g / 100 g 1*1 FL. 30 mL | — | RR | CNS liste positive | ||
| Luxembourg | Celestone Chronodose SP.INJ. 3 mg / 1 mL + 4 mg / 1 mL 1*1 FL.MULTID. 1 ML | — | RR | CNS liste positive | ||
| Luxembourg | Celestone SOL.BUV.GTTES 0,5 mg / 1 mL 1*1 flacon verre 30 mL | — | RR | CNS liste positive | ||
| Luxembourg | Diprophos Disposable Syringe SP.INJ. 5 mg / 1 mL + 2 mg / 1 mL 1*1 seringue prér. 1 mL | — | RR | CNS liste positive | ||
| Luxembourg | Diprophos SP.INJ. 5 mg / 1 mL + 2 mg / 1 mL 1*1 amp. 1 mL | — | RR | CNS liste positive | ||
| Luxembourg | Diprophos SP.INJ. 5 mg / 1 mL + 2 mg / 1 mL 1*1 amp. 2 ml | — | RR | CNS liste positive | ||
| Luxembourg | DIPROSALIC POMM. 0,5 mg / 1 g + 30 mg / 1 g 1*1 tube 30 g | — | RR | CNS liste positive | ||
| MA | Betastene 0.05 % | — | 0.5 MG/ML | Solution Buvable | G | CNOPS liste des medicaments |
| MA | Betastene 2 mg | — | 2 MG | Comprime Dispersible | G | CNOPS liste des medicaments |
| MA | Betneval | — | 0.1 G | Pommade | P | CNOPS liste des medicaments |
| MA | Betneval | — | 0.1 G | Creme | P | CNOPS liste des medicaments |
| MA | Celestene | — | 0.5 MG/ML | Solution Pour Gouttes Buvables | P | CNOPS liste des medicaments |
| MA | Celestene | — | 2 MG | Comprime Dispersible Secable | P | CNOPS liste des medicaments |
| MA | Celestene | — | 4 MG | Solution Injectable | P | CNOPS liste des medicaments |
| MA | Celestene | — | 8 MG | Solution Injectable | P | CNOPS liste des medicaments |
| Malaysia | Bemetha Tablet 0.5mg | Duopharma Manufacturing (Bangi) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Betamethasone-g Tablet 0.5mg | Y.s.p. Industries (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Betapro Cream 0.05% | Pahang Pharmacy Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Betaval Cream 0.1% | Noripharma Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Medisone Cream 0.1% W/W | World Medicare Supplies Sdn Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Uniflex Cream | Xepa-Soul Pattinson (Malaysia) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | YSP Betamethasone Tablet 0.5mg | Y.s.p. Industries (M) Sdn. Bhd. | Prescription | PRODUCT APPROVED | NPRA | |
| Malaysia | Zontron Betasone Cream 0.1%W/W | Teraputics Sdn Bhd | Prescription | PRODUCT APPROVED | NPRA | |
| Malta | Betamethasone Valerate 0.1%w/w Ointment | Central Procurement & Supplies Unit | Ointment | Authorised | Medicines Authority | |
| Netherlands | Celestone Chronodose, suspensie voor injectie 5,7 mg/ml | N.V. Organon | Suspensie voor injectie | Uitsluitend recept | EU national register | |
| Norway | Betamethasone american regent inj væske, susp 30 mg/5 ml | American Regent | 5 | Injeksjonsvæske, suspensjon | Aktiv oppføring | FEST (DMP) |
| Norway | Betapred tab 0,5 mg | Ukjent (2) | 100 | Tablett | Aktiv oppføring | FEST (DMP) |
See every manufacturer of Betamethasone Acetate worldwide →
Regulator price references for Betamethasone Acetate
Published list or reimbursement prices for Betamethasone Acetate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Betnovate 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Cortival 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate 1/2 | Cream 500 micrograms (as valerate) per g, 15 g | 2.50 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Cream 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Diprosone | Ointment 500 micrograms (as dipropionate) per g, 15 g | 3.65 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Antroquoril | Cream 200 micrograms (as valerate) per g, 100 g | 4.93 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate | Cream 1 mg (as valerate) per g, 30 g | 12.95 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Betnovate | Ointment 1 mg (as valerate) per g, 30 g | 12.95 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Celestone Chronodose | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | 15.03 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Celestone Chronodose | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | 15.03 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Austria | Betnesol Brausetabl. | 10St | 1.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Betnesol Augen-, Ohren-, Nasentropf. | 5ml | 5ml | 2.75 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproforte Salbe | 15000mg | 15g | 3.15 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diprosalic Salbe | 15000mg | 15g | 3.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproderm Salbe | 15000mg | 15g | 3.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproderm Creme | 15000mg | 15g | 3.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Soderm 0,5 mg/g + 20 mg/g Lsg. zur Anw. auf der Haut | 30ml | 30ml | 3.35 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diprosalic dermatol. Lsg. | 30ml | 30ml | 4.35 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Betnesol Brausetabl. | 30St | 4.80 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Betnovate Salbe | 30000mg | 30g | 4.90 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Betnovate crinale Lsg. | 30ml | 30ml | 5.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diprophos 1 ml Susp. zur Inj. | 1ml | 1St | 6.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproderm Creme | 30000mg | 30g | 6.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diprosalic Salbe | 30000mg | 30g | 6.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproderm Salbe | 30000mg | 30g | 6.20 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproforte Salbe | 30000mg | 30g | 6.25 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Celestan Biphase Amp. 1 ml | 1ml | 1St | 6.50 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diproderm dermatol. Lsg. | 30ml | 30ml | 6.50 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Diprophos 2 ml Susp. zur Inj. | 2ml | 1St | 9.40 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Solu-Celestan Amp. | 5St | 12.70 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 | |
| Austria | Diprophos 1 ml Susp. zur Inj. | 1ml | 5St | 26.60 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Austria | Celestan Biphase Amp. 1 ml | 1ml | 5St | 27.10 EUR | KVP (Kassenverkaufspreis) | eEKO (Erstattungskodex) | 2026-09-03 |
| Bahrain | Betaderm | 0.1pct | 15G | 0.28 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Betamed | 0.1pct | 15G | 0.48 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Betasone | 0.1pct | 15G | 0.64 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Betasone | 0.1pct | 15G | 0.64 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Bevason | 0.1pct | 20G | 0.65 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Bevason | 20G | 0.65 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Betaderm | 0.1pct | 20G | 0.76 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Betnovate | 0.1pct | 30G | 0.99 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Citadone | 0.6mg/5ml | 100ML | 1.17 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Betnovate | 30ML | 1.34 BHD | retail (max) | NHRA | 2026-09-01 | |
| Bahrain | Diprosone | 0.05pct | 30G | 1.76 BHD | retail (max) | NHRA | 2026-09-01 |
| Bahrain | Diprosone | 0.5mg/1000mg | 30G | 1.76 BHD | retail (max) | NHRA | 2026-09-01 |
| Greece | Movithiol Cream 0,1% Tubx25g | 0.1pct+25000mg | 1.08 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Betnovate Cream 0,1% (W/W) Tubx30g | 0.1pct+30000mg | 1.61 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Osmoran Lot 0.1% W/V(Bet.val) Flx60ml | 0.1pct+60ml | 2.08 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Flogozyme Lot 0,1% W/V Flx50ml | 0.1pct+50ml | 2.11 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | PROPIOCHRONE INJ.SUSP (5+2)MG/1ML BTx1AMPx1ML | 1ml+1ml | 2.86 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | Betnovate Cut.sol 0,1% mg/mL Flx50ml Scalp Applic | 0.1pct+50ml | 3.25 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | CELESTONE CHRONODOSE INJ.SU.RET (3+3)MG/1 ML VIAL BTx1VIALx1ML | 1ml+1ml | 3.35 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Hungary | Diprosalic Kenőcs | 30000mg | 1x30g tubusban | 596.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Hungary | Diprosalic Oldat | 30ml | 1x30ml tartályban | 708.00 HUF | producer price (ex-factory) | NEAK PUPHA | 2026-09-03 |
| Iceland | Betnovat | 1mg/1000mg | plglas | 928.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Betapred | 4mg/1ml | lykjur | 1,239.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Betapred | 4mg/1ml | lykjur | 1,291.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Betnesol | 0.5mg | pakki | 1,852.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Diprosalic | glas | 2,096.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 | |
| Iceland | Betapred | 0.5mg | pakki | 3,229.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Diprosone | 0.05pct | túpa | 4,254.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Diprospan | 7mg/1ml | lykja | 4,975.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Luxembourg | Celestone SOL.BUV.GTTES 0,5 mg / 1 mL 1*1 flacon verre 30 mL | 0.5mg/1ml | 4.02 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | DIPROSALIC SOL.APP.CUT 0,5 mg / 1 g + 20 mg / 1 g 1*1 flacon 30 mL | 0.5mg/1000mg+20mg/1000mg | 7.83 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BETNELAN-V POMM. 0,1 PC 1*1 tube 30 g | 30000mg | 8.76 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | BETNELAN-V SOL.APP.CUT 0,1 g / 100 g 1*1 FL. 30 mL | 100mg/100000mg | 8.76 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Celestone Chronodose SP.INJ. 3 mg / 1 mL + 4 mg / 1 mL 1*1 FL.MULTID. 1 ML | 3mg/1ml+4mg/1ml | 10.36 EUR | reimbursement | CNS liste positive | 2026-09-05 | |
| Luxembourg | Diprophos Disposable Syringe SP.INJ. 5 mg / 1 mL + 2 mg / 1 mL 1*1 seringue prér. 1 mL | 2mg/1ml+5mg/1ml | 10.36 EUR | reimbursement | CNS liste positive | 2026-09-05 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Osurnia (DIN 02438534) marketed in Canada?
Yes. Health Canada lists DIN 02438534 as Marketed as of 06 Oct 2021.
Who holds the Canadian licence for this product?
Dechra Ltd is the company of record in the Health Canada Drug Product Database.
Is Betamethasone Acetate registered outside Canada?
Yes — Nexara Health has matched 816 registrations in 34 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02438534, status date 2021-10-06; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02438534, status date 2021-10-06; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS.
Dechra Ltd — company profileWho else makes Betamethasone AcetateAll Canadian Betamethasone Acetate products
Health Canada Drug Product Database (DPD), DIN 02438534, status date 2021-10-06; national medicine registries: BDA, CNOPS liste des medicaments, CNS liste positive, DH Drug Office, eEKO (Erstattungskodex), EU national register, FEST (DMP), Fimea Perusrekisteri, HPRA, HZZO, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, Medicines Authority, MISPAS, MoH deltio timwn, NEAK PUPHA, NHRA, NPRA, PBS, SUKL DLP; price sources: CNS liste positive, eEKO (Erstattungskodex), Lyfjastofnun lyfjaverdskra, MoH deltio timwn, NEAK PUPHA, NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.